No Data
No Data
Estimating The Intrinsic Value Of Guangxi LiuYao Group Co., Ltd (SHSE:603368)
Key Insights Guangxi LiuYao Group's estimated fair value is CN¥21.40 based on 2 Stage Free Cash Flow to Equity Guangxi LiuYao Group's CN¥21.18 share price indicates it is trading at similar levels a
Express News | The first batch of fund annual reports is out! 10 billion manager's hidden heavy stock holdings revealed
Liuyao Group (603368): High net profit growth in 4Q23 is in line with equity incentive targets
4Q23 net profit grew rapidly. The annual results were in line with equity incentive targets. The company issued a quick 2023 performance report, and achieved operating income/net profit attributable to mother/net profit deducted from non-mother 208.12/8.47/8 in 2023.
Liu Pharmaceutical Group (603368.SH): Net profit increased 20.7% year-on-year in 2023
Gelonghui, March 19丨Liuyao Group (603368.SH) announced its 2023 annual results report. During the reporting period, the company achieved total operating revenue of 208,011.9029 million yuan, an increase of 9.23% over the previous year; net profit attributable to shareholders of listed companies was 8467.639 million yuan, an increase of 20.70% over the previous year. In the pharmaceutical wholesale sector, the company strengthens supplier cooperation, seizes high-quality new products, actively expands SPD projects for pharmaceutical consumables, promotes the implementation of the collection and distribution model, and steadily increases the size of the wholesale market, especially the market share of equipment consumables. In the pharmaceutical retail sector, the company continues to expand to zero
Liu Pharmaceutical Group (603368): Guangxi Pharmaceutical Wholesale Leader Diversified Development of Retail Industry Shapes Second Growth Curve
Core logic: As of 2024/2/27, the company's PE-TTM valuation is only 8.65 times (average PE value 11 times in the past 5 years, 10 times valuation in the past 3 years). The valuation is at a historically low level and has a strong margin of safety
Liu Pharmaceutical Group (603368): Leading regional pharmaceutical distribution, pharmaceutical industry leading cross-regional development
Flexible system+excellent management to build a regional pharmaceutical distribution leader in Guangxi. The predecessor of Liuyao Group was the Liuzhou Pharmaceutical Wholesale Station established in 1953. It was restructured into a private enterprise in 2002. Under the leadership of a flexible system and excellent management, it has been cultivated for a long time
No Data